Skip to the page

Data / Form D filings / TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc.: Form D filings

TuHURA Biosciences, Inc., a biotechnology company in Tampa, FL, filed 10 Form D notices with the SEC between 2016 and 2023. The latest, on December 27, 2023, reports $1.7 million sold of a $15 million offering to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10500 University Center Drive, Tampa, FL, 33612
Phone
(813) 875-6600
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
1252142

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 27, 2023New notice$15,000,000$1,665,000$13,335,0008Dec 11, 2023sec.gov
Jul 11, 2022New notice$20,000,000$9,101,001$10,898,9992Jun 24, 2022sec.gov
Nov 19, 2021New noticeIndefinite$5,100,0004Oct 29, 2021sec.gov
Sep 29, 2021Amendment$11,000,000$3,830,130$7,169,87039Oct 28, 2020sec.gov
Dec 17, 2020New notice$11,000,000$2,679,559$8,320,44124Oct 28, 2020sec.gov
Jul 3, 2019New notice$15,000,000$495,000$14,505,0005Jun 20, 2019sec.gov
Jan 12, 2018Amendment$15,000,000$2,708,818$12,291,18240Aug 11, 2017sec.gov
Aug 21, 2017New notice$7,257,214$1,757,214$5,500,0006Aug 11, 2017sec.gov
Apr 7, 2017Amendment$5,000,000$0$5,000,0000Yet to occursec.gov
Nov 4, 2016New notice$20,000,000$0$20,000,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Patricia LawmanDirector
Dan DearbornExecutive Officer
George NgDirector
Alan ListDirector
James BiancoExecutive Officer, Director
James ManusoDirector
Kiran PatelDirector
Michael LawmanDirector

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Dec 25, 2023 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what TuHURA Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.